10/1
07:36 am
sprc
SciSparc receives FDA approval for trial for Tourette syndrome therapy [Yahoo! Finance]
Medium
Report
SciSparc receives FDA approval for trial for Tourette syndrome therapy [Yahoo! Finance]
9/30
09:29 am
sprc
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment [Yahoo! Finance]
Medium
Report
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment [Yahoo! Finance]
9/30
09:25 am
sprc
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
Low
Report
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
9/26
09:23 am
sprc
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX [Yahoo! Finance]
Low
Report
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX [Yahoo! Finance]
9/26
09:05 am
sprc
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
Medium
Report
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
9/23
02:23 pm
sprc
SciSparc gets U.S. FDA nod to begin phase 2 trial of Tourette Syndrome candidate Sep. 23, 2024 2:18 PM ET By: Jonathan Block , SA News Editor [Seeking Alpha]
Low
Report
SciSparc gets U.S. FDA nod to begin phase 2 trial of Tourette Syndrome candidate Sep. 23, 2024 2:18 PM ET By: Jonathan Block , SA News Editor [Seeking Alpha]
9/23
08:17 am
sprc
SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment
High
Report
SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment
9/18
04:09 pm
sprc
SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment
Medium
Report
SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment
9/16
04:10 pm
sprc
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy [Yahoo! Finance]
High
Report
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy [Yahoo! Finance]
9/16
04:06 pm
sprc
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
High
Report
SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
9/11
07:46 am
sprc
SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax's Direct Import Agreement with Major Chinese Vehicle Manufacturer [Yahoo! Finance]
Low
Report
SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax's Direct Import Agreement with Major Chinese Vehicle Manufacturer [Yahoo! Finance]
9/11
07:40 am
sprc
SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer
Medium
Report
SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer
9/6
07:55 am
sprc
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
Low
Report
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
8/29
04:38 pm
sprc
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment [Yahoo! Finance]
Low
Report
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment [Yahoo! Finance]
8/29
04:25 pm
sprc
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination
Low
Report
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination
8/28
09:09 am
sprc
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million [Yahoo! Finance]
Medium
Report
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million [Yahoo! Finance]
8/28
08:55 am
sprc
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million
Low
Report
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million
8/26
05:26 am
sprc
SciSparc secures final approval in Israel to start Tourette's Syndrome trial [Yahoo! Finance]
Medium
Report
SciSparc secures final approval in Israel to start Tourette's Syndrome trial [Yahoo! Finance]
8/26
05:26 am
sprc
SciSparc seeks FDA IND clearance for Phase IIb Tourette Syndrome treatment trial [Yahoo! Finance]
Medium
Report
SciSparc seeks FDA IND clearance for Phase IIb Tourette Syndrome treatment trial [Yahoo! Finance]
8/23
04:18 pm
sprc
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome [Yahoo! Finance]
High
Report
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome [Yahoo! Finance]
8/23
04:09 pm
sprc
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
Neutral
Report
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome